The Medicine Maker

Exploring the human side of drug manufacturing & development 💊

[The Medicine Maker @medicine_maker]

🌟 Power List 2026

Ann Cleves Jain has spent 25+ years advancing computational drug discovery through innovations in 3D molecular design, predictive pharmacology, and macrocyclic ligand optimization at Optibrium.

Congratulations! 🏆

🔗 https://t.co/gi2Nf8t4aj
#DrugDiscovery

[The Medicine Maker @medicine_maker]

💊 The future of small molecule development is changing fast.

Explore expert insights on API stability, nitrosamine testing, oral dosage innovation, and more in our FREE eBook.

Download now: https://t.co/bdHfBul0wr

Sponsored by @Pfizer and Kindeva
#Pharma #DrugDevelopment

[The Medicine Maker @medicine_maker]

China's biotech sector is growing fast.

Veristat's Daphne Smyth shares what's driving global expansion, the regulatory challenges ahead, and why the industry is watching closely.

Read more: https://t.co/6FIqFzeOnU

#Biotech #DrugDevelopment

[The Medicine Maker @medicine_maker]

🧬 Introducing the Advanced Medicines category in The Medicine Maker #PowerList2026.

Congratulations to the 20 innovators recognized for advancing cell and gene therapies, regenerative medicine, and the future of medicine.

🔗 Explore the full category: https://t.co/y0qoqTfuaB

[The Medicine Maker @medicine_maker]

🚀 The Medicine Maker #PowerList2026: Biopharma is here!

Congratulations to all 20 innovators recognized for advancing biologics, RNA medicines, drug delivery, and the future of biopharma.

🔗 Explore the full rankings: https://t.co/4XKVZAG9BW
#Biopharma #Pharma

[The Medicine Maker @medicine_maker]

🧪 The Medicine Maker #PowerList2026: Small Molecules is here!

Congratulations to all 20 innovators recognized for pushing the boundaries of drug discovery and advancing the future of small molecule medicines.

Explore the full rankings: https://t.co/ZpVPdeoB4l

#DrugDiscovery

[The Medicine Maker @medicine_maker]

🚨 The Medicine Maker #PowerList2026 is live!

Meet the 60 innovators shaping the future of small molecules, biopharma, and advanced medicines.

👏 Congratulations to everyone featured.

🔗 Explore the full list: https://t.co/2iCKJ8s6c2
#SmallMolecules #AdvancedMedicines

[The Medicine Maker @medicine_maker]

❄️ How do you survive biotech's funding winter?

Circio CEO Erik Wiklund shares how the company reinvented itself around circRNA, rebuilt investor confidence, and navigated one of the toughest funding markets in years.

Read more: https://t.co/BXOYnOfRA6
#CircRNA

[The Medicine Maker @medicine_maker]

🤖 What does "good AI practice" look like in drug development?

Crystal Allard and Pratyusha Pallavi examine the new EMA-FDA guiding principles and what they mean for AI governance, oversight, auditability, and risk management in life sciences.

Read on: https://t.co/C2Zz8Ldgo3

[The Medicine Maker @medicine_maker]

At Advanced Therapies London 2026, Alan Griffith of VectorBuilder shares his perspective on the trends, innovations, and strategic priorities influencing the cell and gene therapy landscape.

🎥 Watch the full video: https://t.co/ZsTlnP4K4z

#CellTherapy #GeneTherapy

[The Medicine Maker @medicine_maker]

💊 Michel Savini discusses why scenario planning remains underused, which medicines are most vulnerable to disruption, and how pharma companies can balance resilience with operational efficiency.

Read more: https://t.co/DAQuDE7zn5

[The Medicine Maker @medicine_maker]

💰 How is a changing investment landscape reshaping advanced therapies?

Raphael Ognar of NKILT Therapeutics shares his perspective from #AdvancedTherapiesLondon 2026 on funding, partnerships, and building sustainable paths to patients.

🎥 Watch now: https://t.co/MeFmKZHwBu

[The Medicine Maker @medicine_maker]

Could botulinum toxin help treat chronic neuropathic pain?

@MerzTx_US' Stefan Albrecht discusses why #NeuroScience is entering a new era, and how better biomarkers, patient phenotyping, and digital tools are reshaping #DrugDevelopment.

Read more: https://t.co/gLfQJnewCw

[The Medicine Maker @medicine_maker]

🧬 What will it take to bring advanced cell therapies to more patients worldwide?

Antoinette Gawin, President and CEO of @terumobct, shares her thoughts on leadership, innovation, access, and the future of blood and cell therapy.

Read the interview: https://t.co/aniAln0qKX

[The Medicine Maker @medicine_maker]

What are #GLP1 therapies teaching us about the future of analytical chemistry?

Kelly Broster of @ThermoSci discusses why peptide therapeutics are pushing labs beyond traditional small-molecule workflows + reshaping analytical strategies.

Read in full 👇
https://t.co/3EpLTbfaht

[The Medicine Maker @medicine_maker]

Antoinette Gawin, President and CEO of Terumo Blood and Cell Technologies, shares insights on leadership, innovation, global access, and the evolving ecosystem helping bring advanced therapies to patients worldwide.

Read the full interview 👇
https://t.co/J8DWjJpq2S

[The Medicine Maker @medicine_maker]

🧬 What topics will dominate BIO 2026?

Industry leaders from Ecolab, Kindeva, Quotient Sciences, Ampersand, Sygnature Discovery, Symbiosis, and Accelagen share their predictions on AI, funding, manufacturing, regulation, and M&A 🔗 https://t.co/8bnZAPfrvc

#BIO2026 #Biopharma

[The Medicine Maker @medicine_maker]

💰 Funding is tighter. Expectations are higher.

At #AdvancedTherapiesLondon 2026, Shrinidh Joshi shares how shifting investment trends are reshaping cell & gene therapy, from scalability and partnerships to commercialization.

🎥 Watch now: https://t.co/gNhBQJcuft

[The Medicine Maker @medicine_maker]

Is your lab's data driving decisions or collecting digital dust?

Stephanie Harden and Tracy Hibbs explore why data governance, resilience, and AI readiness are becoming essential for modern laboratories.

Read the full article 👇
https://t.co/7NOfwA2Q3d

#LifeSciences

[The Medicine Maker @medicine_maker]

Pregnant women are often excluded from clinical trials. Could simulation help close the data gap?

Karen Yeo explains how pharmacokinetic modeling is supporting dosing decisions, trial design, and research in pregnancy.

Read more: https://t.co/CqVLDUMsPO

#DrugDevelopment